Literature DB >> 7482643

The clinical meaning of Rankin 'handicap' grades after stroke.

R de Haan1, M Limburg, P Bossuyt, J van der Meulen, N Aaronson.   

Abstract

BACKGROUND AND
PURPOSE: The Rankin Scale is a frequently used handicap index in stroke outcome research. However, relatively little is known about its validity. The purpose of this study was to investigate the clinical meaning of Rankin grades by identifying the functional health aspects that contribute to Rankin scores.
METHODS: We studied 438 patients 6 months after stroke. Data were collected on the following functional health indicators: alertness, communication, independence, disability in activities of daily living, mobility, instrumental disability, social interaction, and recreation. Disability in activities of daily living was assessed with the Barthel Index, whereas the other indicators were measured with subscales of the Sickness Impact Profile. The association between functional health and Rankin Scale was expressed in terms of relative frequencies and Somers' D statistic. Linear regression analysis (after ordinal transformation) was used to identify the significant health factors that explain Rankin scores.
RESULTS: Mobility, disability in daily and instrumental activities, and living arrangements showed a stronger association with Rankin scores (Somers' D range, 0.60 to 0.74) than cognitive and social functioning (Somers' D range, 0.34 to 0.47). Disability in activities of daily living turned out to be the most important explanatory factor of Rankin scores (R2 = 67%).
CONCLUSIONS: The Rankin Scale is not a pure handicap measure but should be viewed as a global functional health index with a strong accent on physical disability. The index is useful as a simple and time-efficient outcome measure in largescale multicenter trials. It is argued that at present there is no clear need to assess handicap as the primary outcome in medically oriented stroke intervention studies.

Entities:  

Mesh:

Year:  1995        PMID: 7482643     DOI: 10.1161/01.str.26.11.2027

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  82 in total

Review 1.  A review of health-related quality-of-life measures in stroke.

Authors:  B A Golomb; B G Vickrey; R D Hays
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Socioeconomic variations in the course of stroke: unequal health outcomes, equal care?

Authors:  G A M van den Bos; J P J M Smits; G P Westert; A van Straten
Journal:  J Epidemiol Community Health       Date:  2002-12       Impact factor: 3.710

Review 3.  Flow-diverter devices in the treatment of intracranial aneurysms: A meta-analysis and systematic review.

Authors:  Xianli Lv; Hongchao Yang; Peng Liu; Youxiang Li
Journal:  Neuroradiol J       Date:  2016-02-02

4.  Duration of Agitation, Fluctuations of Consciousness, and Associations with Outcome in Patients with Subarachnoid Hemorrhage.

Authors:  Michael E Reznik; Ali Mahta; J Michael Schmidt; Hans-Peter Frey; Soojin Park; David J Roh; Sachin Agarwal; Jan Claassen
Journal:  Neurocrit Care       Date:  2018-08       Impact factor: 3.210

5.  Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke.

Authors:  Hagen Kunte; Sein Schmidt; Michael Eliasziw; Gregory J del Zoppo; J Marc Simard; Florian Masuhr; Markus Weih; Ulrich Dirnagl
Journal:  Stroke       Date:  2007-08-02       Impact factor: 7.914

6.  What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2?

Authors:  N Weisscher; M Vermeulen; Y B Roos; R J de Haan
Journal:  J Neurol       Date:  2008-03-14       Impact factor: 4.849

7.  Prolonged elevated heart rate is a risk factor for adverse cardiac events and poor outcome after subarachnoid hemorrhage.

Authors:  J Michael Schmidt; Michael Crimmins; Hector Lantigua; Andres Fernandez; Chris Zammit; Cristina Falo; Sachin Agarwal; Jan Claassen; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

8.  Predictors of neurological deficit after endovascular treatment of cerebral arteriovenous malformations and functional repercussions in prospective follow-up.

Authors:  Jose Jordan; Juan Carlos Llibre; Frank Vazquez
Journal:  Neuroradiol J       Date:  2014-12-01

9.  Endovascular treatment of high-risk tentorial dural arteriovenous fistulas: clinical outcomes.

Authors:  Chuhan Jiang; Xianli Lv; Youxiang Li; Jingbo Zhang; Zhongxue Wu
Journal:  Neuroradiology       Date:  2008-11-07       Impact factor: 2.804

10.  Need for extensive diagnostic work-up for patients with lacunar stroke.

Authors:  Sara Micheli; Giancarlo Agnelli; Francesco Palmerini; Valeria Caso; Michele Venti; Andrea Alberti; Sergio Biagini; Maurizio Paciaroni
Journal:  J Neurol       Date:  2008-02-19       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.